Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy

BACKGROUND: Predicting the long-term prognosis of individuals who experienced sorafenib treatment following partial hepatectomy due to hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) is difficult. This work aims to create an effective prognostic nomogram for HBV related HCC patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Wei, Yan, Kai, Yu, Hua, Huo, Lei, Xian, Zhihong, Zhao, Yanqing, Li, Jutang, Zhang, Yuchan, Cao, Zhenying, Fu, Yong, Cong, Wenming, Dong, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906076/
https://www.ncbi.nlm.nih.gov/pubmed/33643907
http://dx.doi.org/10.3389/fonc.2020.605057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906076/
https://www.ncbi.nlm.nih.gov/pubmed/33643907
http://dx.doi.org/10.3389/fonc.2020.605057

Ejemplares similares